ESR1 Mutations in Cell-Free DNA of Breast Cancer Predictive "Tip of the Iceberg"

被引：4
|
作者：
Fuqua, Suzanne A. W.
Rechoum, Yassine
Gu, Guowei
机构：
[1] Baylor Coll Med, Dept Med, Dan L Duncan Canc Ctr, Lester & Sue Smith Breast Ctr, One Baylor Plaza, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 10期
关键词：
GROWTH;
D O I：
10.1001/jamaoncol.2016.1268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1315 / 1316
页数：3
相关论文
共 50 条
  • [21] ESR1 mutations in metachronous contralateral breast cancer
    Velthuisen, D.
    Akkers, R.
    Menke-Pluijmers, M.
    Kitzen, J.
    Westenend, P.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S124 - S124
  • [22] ESR1 mutations in circulating tumor cell versus circulating cell-free DNA of metastatic breast cancer patients before first-line endocrine therapy and at progression
    Sieuwerts, A. M.
    Beije, N.
    Kraan, J.
    Van, M.
    Onstenk, W.
    Vitale, S. R.
    van der Vlugt-Daane, M.
    Hamberg, P.
    Dirix, L. Y.
    Brouwers, A.
    De Jongh, F. E.
    Jager, A.
    Seynaeve, C. M.
    Jansen, M. P. H. M.
    Foekens, J. A.
    Martens, J. W. M.
    Sleijfer, S.
    CANCER RESEARCH, 2017, 77
  • [23] An optimized workflow to analyze ESR1 mutations in both circulating cell-free and circulating tumor cell DNA by digital PCR
    Vitale, S. R.
    Sieuwerts, A. M.
    Helmijr, J.
    Beije, N.
    van der Vlugt-Daane, M.
    Foekens, J. A.
    Sleijfer, S.
    Jansen, M. P. H. M.
    Martens, J. W. M.
    CANCER RESEARCH, 2017, 77
  • [24] ESR1 mutations confer radiation resistance in breast cancer
    Udden, Nashir
    Wang, Qian
    Alluri, Prasanna G.
    CANCER RESEARCH, 2020, 80 (04)
  • [25] The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer
    Pejerrey, Sasha M.
    Dustin, Derek
    Kim, Jin-Ah
    Gu, Guowei
    Rechoum, Yassine
    Fuqua, Suzanne A. W.
    HORMONES & CANCER, 2018, 9 (04): : 215 - 228
  • [26] ESR1 amplification in breast cancer - A new predictive marker?
    Holst, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (12) : 1226 - 1226
  • [27] ESR1 mutations in metastatic lobular breast cancer patients
    Christine Desmedt
    Julien Pingitore
    Françoise Rothé
    Caterina Marchio
    Florian Clatot
    Ghizlane Rouas
    François Richard
    François Bertucci
    Odette Mariani
    Christine Galant
    Charlotte Fribbens
    Ben O’Leary
    Gert van den Eynden
    Roberto Salgado
    Nicholas C. Turner
    Martine Piccart
    Anne Vincent-Salomon
    Giancarlo Pruneri
    Denis Larsimont
    Christos Sotiriou
    npj Breast Cancer, 5
  • [28] The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer
    Sasha M. Pejerrey
    Derek Dustin
    Jin-Ah Kim
    Guowei Gu
    Yassine Rechoum
    Suzanne A. W. Fuqua
    Hormones and Cancer, 2018, 9 : 215 - 228
  • [29] ESR1 mutations in metastatic lobular breast cancer patients
    Desmedt, Christine
    Pingitore, Julien
    Rothe, Francoise
    Marchio, Caterina
    Clatot, Florian
    Rouas, Ghizlane
    Richard, Francois
    Bertucci, Francois
    Mariani, Odette
    Galant, Christine
    Fribbens, Charlotte
    O'Leary, Ben
    van den Eynden, Gert
    Salgado, Roberto
    Turner, Nicholas C.
    Piccart, Martine
    Vincent-Salomon, Anne
    Pruneri, Giancarlo
    Larsimont, Denis
    Sotiriou, Christos
    NPJ BREAST CANCER, 2019, 5 (1)
  • [30] Serial analysis of ESR1 and PIK3CA mutations in cell-free DNA from metastatic breast cancer during 1st line endocrine therapy
    Baek, Soo Yeon
    Hong, Meehyang
    Lee, Seungah
    Joo, Seulgi
    Jang, JungPil
    Jung, Chinkoo
    Lee, Sae Byul
    Yoo, Tae-Kyung
    Chung, Il Yong
    Kim, Hee Jeong
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Jeong, Hyehyun
    Jeong, Jae Ho
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Lee, Hee Jin
    Kim, Jisun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345